Letrozole in Treating Postmenopausal Women With Metastatic Breast Cancer

Completed · Phase 4

Conditions studied: Breast Cancer

In brief

RATIONALE: Estrogen can stimulate the growth of cancer cells. Letrozole may fight breast cancer by reducing the production of estrogen. PURPOSE: Phase IV trial to study the effectiveness of letrozole in treating postmenopausal women who have metastatic breast cancer that has been previously treated with tamoxifen.

Key facts

Study ID
NCT00014638
Run by
Novartis
Starts
2001-01-01
Expected to finish
2002-03-01
Last updated by the study team
2013-02-21

Who can join

Age: 18 and older. Sex: female. Healthy volunteers: not accepted.

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.